Analysts expect Cirrus Logic, Inc. (NASDAQ:CRUS) to report $1.63 EPS on February, 7.They anticipate $0.13 EPS change or 7.39% from last quarter’s $1.76 EPS. CRUS’s profit would be $103.78M giving it 7.86 P/E if the $1.63 EPS is correct. After having $1.22 EPS previously, Cirrus Logic, Inc.’s analysts see 33.61% EPS growth. The stock decreased 0.25% or $0.13 during the last trading session, reaching $51.22. About 1.14M shares traded or 27.64% up from the average. Cirrus Logic, Inc. (NASDAQ:CRUS) has risen 97.50% since January 30, 2017 and is uptrending. It has outperformed by 80.80% the S&P500.
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company has market cap of $7.82 billion. The firm operates through two divisions, Life Science and Clinical Diagnostics. It has a 328.44 P/E ratio. The Life Science segment develops, makes, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Ratings analysis reveals 50% of Bio-Rad Labs’s analysts are positive. Out of 2 Wall Street analysts rating Bio-Rad Labs, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. BIO was included in 2 notes of analysts from October 13, 2016. The stock of Bio-Rad Laboratories, Inc. (NYSE:BIO) has “Buy” rating given on Thursday, October 13 by CL King. The stock has “Hold” rating by Deutsche Bank on Wednesday, January 18.
The stock increased 0.58% or $1.52 during the last trading session, reaching $263.41. About 134,700 shares traded. Bio-Rad Laboratories, Inc. (BIO) has risen 53.78% since January 30, 2017 and is uptrending. It has outperformed by 37.08% the S&P500.
Tikvah Management Llc holds 13% of its portfolio in Bio-Rad Laboratories, Inc. for 138,007 shares. Beaconlight Capital Llc owns 67,874 shares or 7.96% of their US portfolio. Moreover, Sector Gamma As has 3.71% invested in the company for 109,440 shares. The New York-based Claar Advisors Llc has invested 3.48% in the stock. Hitchwood Capital Management Lp, a New York-based fund reported 350,000 shares.
Analysts await Bio-Rad Laboratories, Inc. (NYSE:BIO) to report earnings on February, 22. They expect $1.27 EPS, up 1.60% or $0.02 from last year’s $1.25 per share. BIO’s profit will be $37.70 million for 51.85 P/E if the $1.27 EPS becomes a reality. After $0.91 actual EPS reported by Bio-Rad Laboratories, Inc. for the previous quarter, Wall Street now forecasts 39.56% EPS growth.
Since January 1, 0001, it had 0 buys, and 3 sales for $1.67 million activity.
Investors sentiment increased to 1.02 in 2017 Q3. Its up 0.08, from 0.94 in 2017Q2. It improved, as 36 investors sold Cirrus Logic, Inc. shares while 105 reduced holdings. 52 funds opened positions while 92 raised stakes. 55.67 million shares or 1.96% less from 56.78 million shares in 2017Q2 were reported. Voya Invest has invested 0.02% in Cirrus Logic, Inc. (NASDAQ:CRUS). Fernwood Investment Mngmt Limited Liability Co invested in 8,560 shares. Price T Rowe Associate Inc Md invested in 0.01% or 758,634 shares. Invesco reported 982,653 shares stake. 147,900 are held by Apg Asset Management Nv. Reinhart holds 0.04% of its portfolio in Cirrus Logic, Inc. (NASDAQ:CRUS) for 6,600 shares. Peak6 Invests Limited Partnership holds 31,209 shares or 0.01% of its portfolio. Morgan Stanley holds 0.02% of its portfolio in Cirrus Logic, Inc. (NASDAQ:CRUS) for 1.38M shares. Whittier Tru accumulated 71 shares. Lord Abbett Limited Liability Company invested in 0.05% or 289,932 shares. Fny Managed Accounts Ltd Liability Corporation holds 0.02% or 300 shares in its portfolio. Suntrust Banks reported 0% stake. Hgk Asset Mgmt Inc reported 11,042 shares. Schwab Charles Investment Management Inc holds 0.02% or 474,299 shares. Jacobs Levy Equity Mgmt has 318,591 shares for 0.33% of their portfolio.
Among 15 analysts covering Cirrus Logic (NASDAQ:CRUS), 10 have Buy rating, 2 Sell and 3 Hold. Therefore 67% are positive. Cirrus Logic had 40 analyst reports since July 23, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained Cirrus Logic, Inc. (NASDAQ:CRUS) rating on Thursday, August 31. KeyBanc Capital Markets has “Buy” rating and $75.0 target. KeyBanc Capital Markets maintained it with “Buy” rating and $70.0 target in Thursday, November 16 report. The rating was initiated by Craig Hallum with “Hold” on Monday, November 21. The firm earned “Buy” rating on Thursday, August 3 by Needham. The stock of Cirrus Logic, Inc. (NASDAQ:CRUS) earned “Buy” rating by Canaccord Genuity on Tuesday, June 21. The stock has “Buy” rating by Stifel Nicolaus on Thursday, November 2. The company was initiated on Monday, November 30 by Dougherty & Company. The firm has “Buy” rating by Canaccord Genuity given on Friday, October 28. The firm earned “Buy” rating on Monday, September 18 by Canaccord Genuity. The stock of Cirrus Logic, Inc. (NASDAQ:CRUS) has “Hold” rating given on Wednesday, September 13 by Craig Hallum.
Cirrus Logic, Inc., a fabless semiconductor company, develops, makes, and markets analog and mixed-signal integrated circuits for a range of consumer and industrial markets. The company has market cap of $3.26 billion. The firm offers portable and non-portable audio, and other products. It has a 12.57 P/E ratio. The Company’s products include analog and mixed-signal audio converters, and digital signal processing products for mobile applications; codecs-chips that integrate analog-to-digital converters and digital-to-analog converters into a single IC; smart codecs, a codec with digital signal processer; amplifiers; micro-electromechanical systems microphones; digital interface products; and standalone digital signal processors.
Since August 2, 2017, it had 0 buys, and 14 sales for $7.89 million activity. KING CHRISTINE had sold 5,000 shares worth $272,544 on Monday, October 16. $949,308 worth of Cirrus Logic, Inc. (NASDAQ:CRUS) shares were sold by Sahota Rashpal. Shares for $391,437 were sold by FLUKE BRADLEY J on Sunday, October 1. The insider Carlson Randolph K sold $3.05 million. SCHUELE ALAN R sold $114,600 worth of stock. Another trade for 14,760 shares valued at $813,220 was sold by Hughes Allan. Tupman David J. sold $67,789 worth of stock.
The post EPS for Cirrus Logic, Inc. (CRUS) Expected At $1.63; Joshua Gold Resources (BIO) Has 0.78 Sentiment appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/01/30/eps-for-cirrus-logic-inc-crus-expected-at-1-63-joshua-gold-resources-bio-has-0-78-sentiment/
No comments:
Post a Comment